Bone Research Society Abstracts 2020
Lists
Only you see this
Abstract
Introduction: Alkaptonuria (AKU) is an iconic autosomal recessive severe multisystem disorder of the tyrosine degradation pathway due to lack of homogentisate dioxygenase resulting in increased circulating and urinary homogentisic acid (HGA), with aortic valve disease and spondyloarthropathy dominating the morbidity. Nitisinone, an inhibitor of hydroxyphenylpyruvate dioxygenase, markedly decreases HGA production and has been used off-label in the National Alkaptonuria Centre (NAC) in Liverpool.
BibTeX
@inproceedings{ranganath2021bone,
author = {L. Ranganath and Milad Khedr and Sobhan Vinjamuri and Eftychia Eirini Psarelli and J.P. Dillon and James A. Gallagher and Larissa Sinkam and Sieyeu Kepseu and Iris Boraschi and René B. Svensson and Frank Rauch and Louis‐Nicolas Veilleux and Amish Chinoy and Alex Ireland and Grace Vassallo and Emma Burkitt‐Wright and Siobhan West and Judith Eelloo and Eileen Hupton and Raja Padidela and Zulf Mughal and Bernard Freudenthal and Riikka E. Mäkitie and John G. Logan and Penny C. Sparkes and Davide Komla Ebri and Andrea S. Pollard and Graham R. Williams and Duncan Bassett and Elizabeth Curtis and Rebecca J Moon and Stefania D’Angelo and Sarah Crozier and Nicholas Bishop and Sujatha Gopal-Kothandapani and Stephen Kennedy and Aris T. Papageorghiou and Robert Fraser and Saurabh Gandhi and Inez Schoenmakers and Ann Prentice and Hazel Inskip and Keith M. Godfrey and M K Javaid and Richard Eastell and Cyrus Cooper and Nicholas C. Harvey and G Li and Q Zheng and E Landao-Bassonga and T Cheng and N Pavlos and Y Ma and C Zhang and M Zheng and G Onambele-Pearson and S Cummings and D Tomlinson},
title = {{Bone Research Society Abstracts 2020}},
booktitle = {JBMR},
year = {2021},
doi = {10.1002/jbm4.10499},
}Loading related content...